Press Releases
You will find all our regulatory press releases in the feed below. Enjoy and share all our other Asarina Pharma news in our regularly updated News Archive.
UPDATE REGARDING THE ASARINA PHARMA SHARE
The Asarina Pharma shares were delisted from NASDAQ First North in October 2024 after an Extraordinary General Meeting decided to liquidate the company. After the delisting, it is no longer possible to trade the Asarina Pharma shares.
In February 2025, Asarina Pharma sold all its IP assets to Relmada Therapeutics, a neurology company in the US (see press release on this website).
After the sale of the IP assets to Relmada, the company is winding its remaining operations and paying its creditors. If there is cash remaining at the end of the liquidation, it will be distributed to the shareholders.